dc.contributor.author | EŞKAZAN, Ahmet Emre | |
dc.date.accessioned | 2021-12-10T10:20:57Z | |
dc.date.available | 2021-12-10T10:20:57Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | EŞKAZAN A. E. , "Asciminib in chronic myeloid leukemia: many questions still remain to be answered", BLOOD CANCER JOURNAL, cilt.11, sa.4, 2021 | |
dc.identifier.issn | 2044-5385 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_39ffb192-d737-43fe-8036-49bbfea92df6 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/169714 | |
dc.identifier.uri | https://doi.org/10.1038/s41408-021-00475-7 | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | Hematoloji | |
dc.subject | Onkoloji | |
dc.subject | Oncology | |
dc.subject | Hematology | |
dc.subject | Health Sciences | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | HEMATOLOJİ | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Asciminib in chronic myeloid leukemia: many questions still remain to be answered | |
dc.type | Makale | |
dc.relation.journal | BLOOD CANCER JOURNAL | |
dc.contributor.department | İstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
dc.identifier.volume | 11 | |
dc.identifier.issue | 4 | |
dc.contributor.firstauthorID | 2634335 | |